Orion Investment Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Hold
16,206
0.11% 62
2026
Q1
$455K Sell
16,206
-394
-2% -$10.5K 0.14% 58
2025
Q4
$413K Hold
16,600
0.13% 59
2025
Q3
$423K Hold
16,600
0.13% 57
2025
Q2
$402K Sell
16,600
-100
-0.6% -$2.33K 0.14% 58
2025
Q1
$423K Hold
16,700
0.17% 54
2024
Q4
$443K Hold
16,700
0.18% 49
2024
Q3
$483K Hold
16,700
0.19% 49
2024
Q2
$467K Buy
+16,700
New +$460K 0.19% 47

Other funds holding PFE

Orion Investment Company's PFE Position: Q2 2026 in Review

Orion Investment Company held its Pfizer (PFE) position steady in Q2 2026 at 16,206 shares worth $390K. The position accounts for 0.11% of the portfolio, ranked #62.

Orion Investment Company first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $483K in Q3 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Orion Investment Company held 16,206 shares of Pfizer worth $390K as of Q2 2026.
  • Orion Investment Company left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.11% of Orion Investment Company's portfolio in Q2 2026, its #62 holding.
  • Orion Investment Company first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Orion Investment Company's Pfizer position peaked at $483K in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.